AI English summary of an SEC filing — figures as filed
The company said its board approved the appointment of Nicolas Papadopoulo as Chief Executive Officer and as a member of the board, effective October 13, 2024. The company said Amendment No. 1 to this filing provides additional disclosures under Item 5.02(c)(3) and Item 5.02(d)(3).
Key points
AI summaryThe company said its board approved the appointment of Nicolas Papadopoulo as Chief Executive Officer and as a member of the board, effective October 13, 2024. The company said Amendment No. 1 to this filing provides additional disclosures under Item 5.02(c)(3) and Item 5.02(d)(3).
Arch Capital Group said the board appointed Nicolas Papadopoulo to the board's Executive Committee on November 7, 2024, effective immediately.
The company said on November 7, 2024, the Compensation and Human Capital Committee approved a special Outperformance Award for Mr. Papadopoulo, consisting of premium-priced stock options and time-vested restricted shares. The grant date is November 19, 2024, and the total grant date value is $23 million, of which seventy percent is in stock options and 30% is in restricted shares.
The company said the stock options will have an exercise price equal to 1.685 times the closing price of its common shares on the grant date and will vest in full on the 3rd anniversary of the grant date. The restricted shares will vest in 3 equal installments on the 1st through 3rd anniversaries of the grant date. Mr. Papadopoulo must hold the net shares received on exercise for 2 years and the net shares received on vesting until the 5th anniversary of the grant date, except in the event of death or a change in control.
Summary
AI-writtenAnalysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.
Correction to CEO Appointment Disclosure (Amendment No. 1)
The company said its board approved the appointment of Nicolas Papadopoulo as Chief Executive Officer and as a member of the board, effective October 13, 2024. The company said Amendment No. 1 to this filing provides additional disclosures under Item 5.02(c)(3) and Item 5.02(d)(3).
Source · Based on the filing body and exhibits
Appointment to Executive Committee
Arch Capital Group said the board appointed Nicolas Papadopoulo to the board's Executive Committee on November 7, 2024, effective immediately.
Source · Based on the filing body and exhibits
Size and Structure of Special Outperformance Award
The company said on November 7, 2024, the Compensation and Human Capital Committee approved a special Outperformance Award for Mr. Papadopoulo, consisting of premium-priced stock options and time-vested restricted shares. The grant date is November 19, 2024, and the total grant date value is $23 million, of which seventy percent is in stock options and 30% is in restricted shares.
Source · Based on the filing body and exhibits
Stock Option Exercise Price, Vesting and Holding Terms
The company said the stock options will have an exercise price equal to 1.685 times the closing price of its common shares on the grant date and will vest in full on the 3rd anniversary of the grant date. The restricted shares will vest in 3 equal installments on the 1st through 3rd anniversaries of the grant date. Mr. Papadopoulo must hold the net shares received on exercise for 2 years and the net shares received on vesting until the 5th anniversary of the grant date, except in the event of death or a change in control.
Source · Based on the filing body and exhibits
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…